BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26845400)

  • 21. Danger of cancerous tissue development in chromosomal abnormalities.
    Pak J Biol Sci; 2011 Feb; 14(3):245-6. PubMed ID: 21870652
    [No Abstract]   [Full Text] [Related]  

  • 22. Stem cell therapy: challenges ahead.
    Bhagavati S
    Indian J Pediatr; 2015 Mar; 82(3):286-91. PubMed ID: 24992980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing commercial opportunities for autologous and allogeneic cell-based products.
    Smith DM
    Regen Med; 2012 Sep; 7(5):721-32. PubMed ID: 22954441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Induced pluripotent stem cells: youthful indiscretions].
    Qiang B; Hamamah S; De Vos J
    Med Sci (Paris); 2011 Oct; 27(10):805-7. PubMed ID: 22027413
    [No Abstract]   [Full Text] [Related]  

  • 25. How iPS cells changed the world.
    Scudellari M
    Nature; 2016 Jun; 534(7607):310-2. PubMed ID: 27306170
    [No Abstract]   [Full Text] [Related]  

  • 26. Stem Cells in the Treatment of Disease.
    Blau HM; Daley GQ
    N Engl J Med; 2019 May; 380(18):1748-1760. PubMed ID: 31042827
    [No Abstract]   [Full Text] [Related]  

  • 27. What's old is new again: Autologous stem cell transplant for AMD.
    Byrne LC
    Sci Transl Med; 2017 Apr; 9(387):. PubMed ID: 28446683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Good practice.
    Nature; 2014 Jun; 510(7504):187-8. PubMed ID: 24926498
    [No Abstract]   [Full Text] [Related]  

  • 29. [Retinal regeneration with iPS cells ‒ Clinical trials for retinal degenerative disorders].
    Sugita S
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(2):79-85. PubMed ID: 26016634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autologous stem cell therapy for inherited and acquired retinal disease.
    Apatoff MBL; Sengillo JD; White EC; Bakhoum MF; Bassuk AG; Mahajan VB; Tsang SH
    Regen Med; 2018 Jan; 13(1):89-96. PubMed ID: 29360008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem cells cruise to clinic.
    Cyranoski D
    Nature; 2013 Feb; 494(7438):413. PubMed ID: 23446394
    [No Abstract]   [Full Text] [Related]  

  • 32. Trials of embryonic stem cells to launch in China.
    Cyranoski D
    Nature; 2017 May; 546(7656):15-16. PubMed ID: 28569831
    [No Abstract]   [Full Text] [Related]  

  • 33. Japan stem-cell trial stirs envy.
    Reardon S; Cyranoski D
    Nature; 2014 Sep; 513(7518):287-8. PubMed ID: 25230622
    [No Abstract]   [Full Text] [Related]  

  • 34. Stem cell-based treatments for Type 1 diabetes mellitus: bone marrow, embryonic, hepatic, pancreatic and induced pluripotent stem cells.
    Godfrey KJ; Mathew B; Bulman JC; Shah O; Clement S; Gallicano GI
    Diabet Med; 2012 Jan; 29(1):14-23. PubMed ID: 21883442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induced Pluripotent Stem Cell (iPSC)-Derived Exosomes for Precision Medicine in Heart Failure.
    Yang PC
    Circ Res; 2018 Mar; 122(5):661-663. PubMed ID: 29496797
    [No Abstract]   [Full Text] [Related]  

  • 36. [The role of cost analysis in the evaluation of the development of medical technology. The case of allogenic stem-cell transplantation].
    Groot MT; van Agthoven M; Löwenberg B; Willemze R; Uyl-de Groot CA
    Ned Tijdschr Geneeskd; 2004 Mar; 148(10):480-4. PubMed ID: 15042895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene and Cell Therapies: Inserm at the Heart of Biomedical Revolutions.
    Lévy Y
    Hum Gene Ther; 2016 Feb; 27(2):98-9. PubMed ID: 26886831
    [No Abstract]   [Full Text] [Related]  

  • 38. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins.
    Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO
    J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Langmuir-Schaefer film deposition onto honeycomb porous films for retinal tissue engineering.
    Calejo MT; Ilmarinen T; Vuorimaa-Laukkanen E; Talvitie E; Hakola HM; Skottman H; Kellomäki M
    Acta Biomater; 2017 May; 54():138-149. PubMed ID: 28223209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of novel therapies using human iPS cell-derived retinal pigment epithelia].
    Arakawa D; Ito A; Osakada F
    Nihon Yakurigaku Zasshi; 2016; 148(4):217. PubMed ID: 27725570
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.